Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Doxifluridine Capsules
Indication: This product is used to treat breast cancer, gastric cancer, colon cancer, rectal cancer, nasopharyngeal cancer, and cervical cancer.
Doxifluridine Capsules
Indication: This product is used to treat breast cancer, gastric cancer, colorectal cancer, nasopharyngeal cancer, and cervical cancer.
Manufacturer:
PKU HealthCare Corp., Ltd.
Mitomycin for injection
Indication: It is mainly suitable for gastric cancer, lung cancer, breast cancer, and also for liver cancer, pancreatic cancer, colorectal cancer, esophageal cancer, ovarian cancer and cancerous intracavitary effusion.
Manufacturer:
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
Mitomycin for injection
Indication: It is mainly suitable for gastric cancer, lung cancer, breast cancer, and also for liver cancer, pancreatic cancer, colorectal cancer, esophageal cancer, ovarian cancer and cancerous intracavitary effusion.
Manufacturer:
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
Mitomycin for injection
Indication: It is mainly suitable for gastric cancer, lung cancer, breast cancer, and also for liver cancer, pancreatic cancer, colorectal cancer, esophageal cancer, ovarian cancer and cancerous intracavitary effusion.
Manufacturer:
Han Hui Pharmaceuticals Company Limited
Mitomycin for injection
Indication: It is mainly suitable for gastric cancer, lung cancer, breast cancer, and also for liver cancer, pancreatic cancer, colorectal cancer, esophageal cancer, ovarian cancer and cancerous intracavitary effusion.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Mitomycin for injection
Indication: It is mainly suitable for gastric cancer, lung cancer, breast cancer, and also for liver cancer, pancreatic cancer, colorectal cancer, esophageal cancer, ovarian cancer and cancerous intracavitary effusion.
Capecitabine Tablets
Indication: FDA approved for the treatment of metastatic breast cancer that is resistant to conventional therapies and for the treatment of metastatic colorectal cancer in combination with Taxotere for the treatment of advanced breast cancer.
Capecitabine Tablets
Indication: FDA approved for the treatment of metastatic breast cancer that is resistant to conventional therapies and for the treatment of metastatic colorectal cancer in combination with Taxotere for the treatment of advanced breast cancer.
Related Ingredients